Yale Univ., New Haven, CT. Addresses the quantitative evaluation of HIV prevention programs. Describes quantitative approaches with an emphasis on statistical methods. Also presents articles discussing AIDS policy modeling, forecasting, infectivity and disease progression, and risky behavior.
Foreword
ix
Donald L. Thomsen, Jr.
Introduction
1
(12)
Edward H. Kaplan
Ron Brookmeyer
Part I: Evaluating HIV Prevention Programs: Context and Concepts
Overview of HIV Prevention Programs in Developing Countries
13
(19)
Michael H. Merson
Julia M. Dayton
Implications of Economic Evaluations for National HIV Prevention Policy Makers
32
(23)
David R. Holtgrave
Steven D. Pinkerton
Statistical Issues in HIV Prevention
55
(24)
Ron Brookmeyer
Epidemiological Issues in the Evaluation of HIV Prevention Programs
79
(18)
Nancy S. Padian
Stephen C. Shiboski
Part II: Cost-Effectiveness and Resource Allocation
Difficult Choices, Urgent Needs: Optimal Investment in HIV Prevention Programs
97
(21)
Margaret L. Brandeau
Methadone Treatment as HIV Prevention: Cost-Effectiveness Analysis
118
(25)
Harold Pollack
Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use
143
(32)
Douglas K. Owens
Donna M. Edwards
Ross D. Shachter
Part III: Case Studies
Harm Reduction in Rome: A Model-Based Evaluation of Its Impact on the HIV-1 Epidemic
175
(14)
Massimo Arca
Teresa Spadea
Giulia Cesaroni
Marina Davoli
Annette D. Verster
Carlo A. Perucci
Evaluating Israel's Ethiopian Blood Ban
189
(13)
Edward H. Kaplan
Feeding Strategies for Children of HIV-Infected Mothers: Modeling the Trade-Off Between HIV Infection and Non-HIV Mortality
202
(21)
James G. Kahn
Elliot Marseille
Joseph Saba
Part IV: New Methods for New Problems
Design of HIV Trials for Estimating External Effects
223
(18)
Tomas Philipson
Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines
241
(19)
Ira M. Longini, Jr.
Michael G. Hudgens
M. Elizabeth Halloran
Health Policy Modeling: Epidemic Control, HIV Vaccines, and Risky Behavior
260
(30)
Sally Blower
Katia Koelle
John Mills
Development and Validation of a Serologic Testing Algorithm for Recent HIV Seroconversion
290
(15)
Glen A. Satten
Robert S. Janssen
Susan Stramer
Michael P. Busch
Issues in Quantitative Evaluation of Epidemiologic Evidence for Temporal Variability of HIV Infectivity
305
(26)
Stephen C. Shiboski
Nancy S. Padian
Index
331
What is included with this book?
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.
Please wait while the item is added to your bag...
×
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description,
with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.